A drug called Leqembi, which modestly slows progression of the disease, is expected soon to receive full approval from federal regulators.
For Alzheimer’s patients, a new era of treatment brings hope and risk
A drug called Leqembi, which modestly slows progression of the disease, is expected soon to receive full approval from federal regulators.